<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Hydrogen-oxygen inhalation for treatment of COVID-19</title>
    <subTitle>with commentary from Zhong Nanshan</subTitle>
  </titleInfo>
  <name type="personal">
    <namePart>Xu, Kecheng</namePart>
    <namePart type="date">1940-</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <name type="personal">
    <namePart>Nanshan, Zhong.</namePart>
  </name>
  <typeOfResource>text</typeOfResource>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">si</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Hackensack, NJ</placeTerm>
    </place>
    <publisher>World Scientific Publishing</publisher>
    <dateIssued>c2021</dateIssued>
    <dateIssued encoding="marc">2021</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>xlii, 221 p. : col. ill.</extent>
  </physicalDescription>
  <tableOfContents>Part 1 Hydrogen Gas and Its Biological Effects -- Part 2 Effects of Hydrogen on Experimental Lung Damage -- Part 3 Pathogenesis of Viral Infectious Lung Diseases -- Part 4 Oxidative Stress and ROS During Viral Respiratory Infections -- Part 5 Studies on Lung Diseases with Hydrogen-Oxygen Treatment -- Part 6 Rationality of Application of Hydrogen-Oxygen Inhalation for COVID-19 -- Part 7 Clinical Use of Hydrogen-Oxygen Inhalation for Treatment of COVID-19.</tableOfContents>
  <note type="statement of responsibility">Kecheng Xu.</note>
  <note>Includes bibliographical references and index</note>
  <subject>
    <topic>Coronavirus Infections</topic>
    <topic>Therapy</topic>
  </subject>
  <subject>
    <topic>Hydrogen</topic>
    <topic>Therapeutic use</topic>
  </subject>
  <subject>
    <topic>Oxygen inhalation therapy</topic>
  </subject>
  <subject>
    <topic>Pneumonia, Viral</topic>
    <topic>Therapy</topic>
  </subject>
  <subject>
    <topic>Betacoronavirus</topic>
  </subject>
  <classification authority="nlm">WC505 .X825 2021</classification>
  <identifier type="isbn">9789811223297</identifier>
  <identifier type="isbn">9811223297</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">TULIB</recordContentSource>
    <recordCreationDate encoding="marc">210329</recordCreationDate>
    <recordIdentifier source="OCoLC">on1243492508</recordIdentifier>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
